Economics and health-related quality of life in antiemetic therapy: recommendations for trial design

This publication has 28 references indexed in Scilit:

• 5-HT3 receptor antagonists: Differences and similarities
  European Journal Of Cancer, 1997
• Anti-emesis with cancer chemotherapy
  European Journal Of Cancer, 1997
• Comparative studies of various antiemetic regimens
  Supportive Care in Cancer, 1996
• On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993
  Annals of Oncology, 1996
• Pharmacoeconomic Aspects in the Treatment of Curable and Incurable Cancer
  PharmacoEconomics, 1995
• European School of Oncology advisory report to the Commission of the European Communities for the “Europe against cancer programme” cost-effectiveness in cancer care
  European Journal Of Cancer, 1995
• The real costs of emesis—An economic analysis of ondansetron vs. Metoclopramide in controlling emesis in patients receiving chemotherapy for cancer
  European Journal Of Cancer, 1993
• Control of Chemotherapy-Induced Emesis
  New England Journal of Medicine, 1993
• Ondansetron: A Cost-Effective Advance in Anti-Emetic Therapy
  Oncology, 1993
• On the receiving end—patient perception of the side-effects of cancer chemotherapy
  European Journal of Cancer and Clinical Oncology, 1983